http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104056276-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate | 2013-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104056276-B |
| titleOfInvention | Influenza virus attenuated live vaccine and preparation method thereof |
| abstract | The invention discloses an influenza virus attenuated live vaccine with a preservation number of CCTCCNO: V201302, which is obtained based on mutation of M gene, the vaccine candidate strain has good gene stability, and attenuation characteristic and has strong immunogenicity, can induce a specific serum antibody of influenza virus and a mucous membrane antibody, and can induce different subgroups for generating T cell and quantity of CD8＜+＞T cells for secreting the IFN-gamma. Under current production capability and technology, immunization population can be effectively enlarged, and the influenza virus attenuated live vaccine has important social meaning and usage value during a flu period. |
| priorityDate | 2013-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.